Dose-effect relationship between smoking and blood rheology

Area of Science:

• Hematology
• Cardiovascular Physiology
• Public Health

Background:

• Smoking is a major risk factor for cardiovascular diseases.
• Understanding the impact of smoking on blood properties is crucial for public health.
• Previous research indicates smoking affects various blood parameters.

Purpose of the Study:

• To investigate the dose-dependent effects of smoking on hemorheologic variables in male blood donors.
• To determine if these smoking-induced changes are reversible.

Main Methods:

• Comparison of five groups of male blood donors based on smoking habits (never, ex-smokers, light, moderate, heavy smokers).
• Measurement of hematocrit, white cell count, plasma and blood viscosity, blood cell filterability and aggregation, plasma colloid oncotic pressure, and fibrinogen.
• Statistical analysis to assess the relationship between smoking dose and hemorheologic variables.

Main Results:

• A progressive and significant deterioration in hemorheologic variables was observed with increasing smoking dose.
• Changes included increased viscosity, hematocrit, and white cell count, suggesting polycythemia and inflammation.
• These adverse effects were found to be reversible in ex-smokers.

Conclusions:

• Smoking induces a dose-related increase in blood viscosity among young men.
• The observed hemorheologic changes are linked to polycythemia and potential chronic inflammation.
• Smoking cessation can reverse these detrimental effects on blood viscosity.